Key Takeaways Medical device maker Becton Dickinson (BD) is buying the Critical Care product division of Edwards Lifesciences ...
Becton, Dickinson and Company BDX, popularly known as BD, recently announced a definitive agreement to acquire Edwards ...
Acquisition expands BD's portfolio of smart connected care solutions, advanced AI-enabled clinical decision tools, and ...
The FDA says Medline initiated additional recalls as the company grapples with issues surrounding syringes made in China.
Prefilled Syringes Drug Molecules Market is valued at US$ 70,177.9 million in 2024 and at a CAGR of 6% on a valuation of US$ ...
According to a new analysis by Future Market Insights (FMI), the Prefilled Syringes Drug Molecules Market is expected to witness a steady Compound Annual Growth Rate (CAGR) of 6% over the next decade ...
1 Day JMISMDL 0.49% DJIA -0.22% S&P 500 -0.11% Health Care/Life Sciences 0.67% ...
Notably, BD Medical increased domestic production of syringes, a move likely to positively impact future revenue. BD Life Sciences entered a strategic partnership to enhance cervical cancer ...
The BD Medical segment provides peripheral intravenous ... hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems ...